Published in Endocrine on July 16, 2015
25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation (2005) 2.71
Characterization of normocalcemic primary hyperparathyroidism. Am J Med (2004) 1.69
Absence of peroxisome proliferator-activated receptor-alpha abolishes hypertension and attenuates atherosclerosis in the Tsukuba hypertensive mouse. Hypertension (2007) 1.50
Support for religio-political aggression among teenaged boys in Gaza: part II: neuroendocrinological findings. Aggress Behav (2010) 1.41
Attempted forced titration of blood pressure to <130/85 mm Hg in type 2 diabetic hypertensive patients in clinical practice: the diastolic cost. J Clin Hypertens (Greenwich) (2006) 1.41
PANCREATIC INCIDENTALOMA: DIFFERENTIATING NONFUNCTIONING PANCREATIC NEUROENDOCRINE TUMORS FROM INTRAPANCREATIC ACCESSORY SPLEEN. Endocr Pract (2016) 1.39
Non-functioning pituitary adenomas. Best Pract Res Clin Endocrinol Metab (2009) 1.14
Ghrelin secretion is modulated in a nutrient- and gender-specific manner. Clin Endocrinol (Oxf) (2004) 1.10
Idiopathic intracranial hypertension is associated with lower body adiposity. Ophthalmology (2009) 1.07
Neural traces of stress: cortisol related sustained enhancement of amygdala-hippocampal functional connectivity. Front Hum Neurosci (2013) 1.02
The 5 lipoxygenase system in the vasculature: emerging role in health and disease. Mol Cell Endocrinol (2006) 0.98
Estrogen-like activity of licorice root constituents: glabridin and glabrene, in vascular tissues in vitro and in vivo. J Steroid Biochem Mol Biol (2004) 0.98
Prevalence of hypertension in type 2 diabetes mellitus: impact of the tightening definition of high blood pressure and association with confounding risk factors. J Cardiometab Syndr (2006) 0.92
Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells. Am J Hypertens (2008) 0.92
Postnatal ablation of POMC neurons induces an obese phenotype characterized by decreased food intake and enhanced anxiety-like behavior. Mol Endocrinol (2013) 0.90
Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men. Eur J Endocrinol (2009) 0.89
Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism. Eur J Endocrinol (2010) 0.89
Pyrimethamine increases β-hexosaminidase A activity in patients with Late Onset Tay Sachs. Mol Genet Metab (2010) 0.89
Adipose tissue renin-angiotensin-aldosterone system (RAAS) and progression of insulin resistance. Mol Cell Endocrinol (2012) 0.88
Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model. Diabetes (2012) 0.88
Is obesity a brain disease? Neurosci Biobehav Rev (2013) 0.85
Hyperandrogenism is associated with earlier age of onset of idiopathic intracranial hypertension in women. Curr Eye Res (2013) 0.84
Synthesis and evaluation of the antiproliferative activities of derivatives of carboxyalkyl isoflavones linked to N-t-Boc-hexylenediamine. J Med Chem (2007) 0.84
The effects of direct factor Xa inhibitor (Rivaroxaban) on the human osteoblastic cell line SaOS2. Connect Tissue Res (2012) 0.83
Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation. Metabolism (2010) 0.82
Elucidation of mechanisms of the reciprocal cross talk between gonadotropin-releasing hormone and prostaglandin receptors. Endocrinology (2010) 0.81
25 hydroxy-vitamin D(3)-1alpha hydroxylase expression and activity in cultured human osteoblasts and their modulation by parathyroid hormone, estrogenic compounds and dihydrotestosterone. J Steroid Biochem Mol Biol (2007) 0.81
A non-calcemic Vitamin D analog modulates both nuclear and putative membranal estrogen receptors in cultured human vascular smooth muscle cells. J Steroid Biochem Mol Biol (2004) 0.80
Lipoxygenase metabolites are mediators of PTH-dependent human osteoblast growth. Bone (2007) 0.80
Testosterone is a strong correlate of ghrelin levels in men and postmenopausal women. Neuroendocrinology (2008) 0.80
Support for religio-political aggression among teenaged boys in Gaza: Part I: psychological findings. Aggress Behav (2010) 0.80
Dietary cinnamon supplementation and changes in systolic blood pressure in subjects with type 2 diabetes. J Med Food (2011) 0.80
Serum cortisol levels in patients admitted to the department of medicine: Prognostic correlations and effects of age, infection, and comorbidity. Am J Med Sci (2006) 0.80
Estrogens and hyperglycemic modulation of mRNAs expressions involved in bone metabolism: an overshadowed association? Connect Tissue Res (2013) 0.79
Obesity in elderly subjects: in sheep's clothing perhaps, but still a wolf! Diabetes Care (2009) 0.79
High glucose blocks the effects of estradiol on human vascular cell growth: differential interaction with estradiol and raloxifene. J Steroid Biochem Mol Biol (2004) 0.79
Cortisol response and desire to binge following psychological stress: comparison between obese subjects with and without binge eating disorder. Psychiatry Res (2012) 0.79
Fat cell-derived modulators of vascular cell pathophysiology: the list keeps growing. J Cardiometab Syndr (2006) 0.79
Role of putative membrane receptors in the effects of estradiol on human vascular cell growth. Am J Hypertens (2004) 0.79
Rivaroxaban, a direct inhibitor of the coagulation factor Xa interferes with hormonal-induced physiological modulations in human female osteoblastic cell line SaSO2. J Steroid Biochem Mol Biol (2013) 0.79
Aldosterone up-regulates 12- and 15-lipoxygenase expression and LDL oxidation in human vascular smooth muscle cells. J Cell Biochem (2009) 0.78
Diabetes modulates differentially creatine kinase-specific activity responsiveness to estradiol-17beta and to raloxifene in rat organs. J Cell Biochem (2006) 0.78
How should a nonfunctioning pituitary macroadenoma be monitored after debulking surgery? Clin Endocrinol (Oxf) (2009) 0.78
Dihydrotestosterone and estradiol-17beta mutually neutralize their inhibitory effects on human vascular smooth muscle cell growth in vitro. J Steroid Biochem Mol Biol (2008) 0.78
Angiotensin II increases the expression of lectin-like oxidized low-density lipoprotein receptor-1 in human vascular smooth muscle cells via a lipoxygenase-dependent pathway. Am J Hypertens (2005) 0.78
Prophylactic treatment with telmisartan induces tissue-specific gene modulation favoring normal glucose homeostasis in Cohen-Rosenthal diabetic hypertensive rats. Metabolism (2011) 0.78
Less calcemic Vitamin D analogs enhance creatine kinase specific activity and modulate responsiveness to gonadal steroids in the vasculature. J Steroid Biochem Mol Biol (2006) 0.77
Diastolic pressure in type 2 diabetes: can target systolic pressure be reached without "diastolic hypotension"? Diabetes Care (2008) 0.77
Sex specific response of cultured human bone cells to ERα and ERβ specific agonists by modulation of cell proliferation and creatine kinase specific activity. J Steroid Biochem Mol Biol (2011) 0.77
DT56a (Femarelle): a natural selective estrogen receptor modulator (SERM). J Steroid Biochem Mol Biol (2007) 0.77
GENDER DETERMINES SERUM FREE CORTISOL: HIGHER LEVELS IN MEN. Endocr Pract (2016) 0.77
Modulation of the response to estradiol-17beta of rat vascular tissues by a non calcemic vitamin D analog. J Steroid Biochem Mol Biol (2004) 0.76
Gonadotropin-releasing hormone activates the 12-lipoxygenase pathway in the LbetaT2 gonadotrope cell line. Neuroendocrinology (2003) 0.76
A daidzein-daunomycin conjugate improves the therapeutic response in an animal model of ovarian carcinoma. J Steroid Biochem Mol Biol (2008) 0.76
A single-step approach to the diagnosis of primary hyperaldosteronism: filling a true void or burdening the bottleneck of adrenal vein sampling? J Clin Hypertens (Greenwich) (2014) 0.75
Low-dose calcitriol decreases aortic renin, blood pressure, and atherosclerosis in apoe-null mice. J Atheroscler Thromb (2012) 0.75
Letter to the editor: Thiazides are not inducers of PTH secretion: a comment on normocalcemic hyperparathyroidism. J Clin Endocrinol Metab (2015) 0.75
The appearance of aggregated erythrocytes in the peripheral blood of individuals with insulin resistance. Diabetes Metab Res Rev (2003) 0.75
Renal and systemic effects of endothelin-1 in diabetic-hypertensive rats. Clin Exp Hypertens (2011) 0.75
The obesity pattern of idiopathic intracranial hypertension in men. Graefes Arch Clin Exp Ophthalmol (2013) 0.75
Establishing Normal Ranges of Basal and ACTH-Stimulated Serum Free Cortisol in Children. Horm Res Paediatr (2016) 0.75
LBOS 01-02 CLUSTERING OF SILENT HYPOTENSIVE EPISODES IN THE MORNING/LATE-MORNING HOURS IN SUBJECTS TREATED FOR HYPERTENSION. J Hypertens (2016) 0.75
Anti-proliferative effects of a novel isoflavone derivative in medullary thyroid carcinoma: an in vitro study. J Steroid Biochem Mol Biol (2012) 0.75
Thyroid cysts: a new extra-adrenal site of aldosterone synthase expression and increased aldosterone content. Clin Endocrinol (Oxf) (2007) 0.75
12S-lipoxygenase protein associates with alpha-actin fibers in human umbilical artery vascular smooth muscle cells. Biochem Biophys Res Commun (2007) 0.75
Low achieved diastolic pressure in tightly controlled mid-older hypertensive subjects is associated with favorable arterial properties. Clin Exp Hypertens (2011) 0.75
Serum free cortisol as an ancillary tool in the interpretation of the low-dose 1-μg ACTH test. Clin Endocrinol (Oxf) (2011) 0.75
In the Treatment of Hypertension, Lowering of Diastolic Pressure to <70 mm Hg Is Often Unavoidable. J Am Coll Cardiol (2017) 0.75
Growth inhibition of human thyroid carcinoma and goiter cells in vitro by the isoflavone derivative 7-(O)-carboxymethyl daidzein conjugated to N-t-boc-hexylenediamine. Thyroid (2012) 0.75
KISS1 receptor is preferentially expressed in clinically non-functioning pituitary tumors. Pituitary (2015) 0.75
LBOS 01-02 CLUSTERING OF SILENT HYPOTENSIVE EPISODES IN THE MORNING/LATE-MORNING HOURS IN SUBJECTS TREATED FOR HYPERTENSION. J Hypertens (2016) 0.75